Nepal measles outbreak response immunization during COVID-19: A risk-based intervention strategy

Anindya Sekhar Bose1, Pasang Rai2, Binod Prasad Gupta3

  • 1World Health Organization (WHO), Department of Immunization Vaccines and Biologicals (IVB), Geneva, Switzerland.

Vaccine
|March 18, 2022
PubMed

Insights

Nepal

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization Programs

Background:

  • Measles outbreaks pose a significant public health threat, exacerbated by concurrent health crises like the COVID-19 pandemic.
  • Nepal's National Immunization Programme (NIP) faced challenges in managing measles outbreaks amidst ongoing COVID-19 transmission in 2020.
  • Timely and effective outbreak response is crucial to curb measles spread and prevent mortality.

Purpose of the Study:

  • To describe the decision-making framework used by Nepal's NIP for implementing measles outbreak response immunization (ORI) during the COVID-19 pandemic.
  • To evaluate the effectiveness of the ORI campaign in controlling measles incidence.
  • To highlight key factors contributing to the successful implementation of mass vaccination during a pandemic.

Main Methods:

  • A logical decision-making framework was developed and applied, integrating data from measles and COVID-19 surveillance, immunization coverage, and program capacity.
  • The framework informed 'Go/No-Go' decisions for ORI interventions, reviewed by the National Immunization Advisory Committee (NIAC).
  • Outbreak response strategies, including ORI, vitamin A administration, and case management, were implemented in affected areas.

Main Results:

  • Measles outbreak response immunization (ORI) was implemented in four districts, alongside ongoing measles-rubella supplemental immunization activities (SIA).
  • Over 32,000 individuals were vaccinated during the ORI, achieving 97% coverage.
  • Measles incidence decreased by 98% following the ORI, with a 94-fold reduction in daily incidence rate compared to the pre-intervention period.

Conclusions:

  • The study demonstrates the feasible application of a simple, data-driven decision-making framework for implementing mass vaccination campaigns during the COVID-19 pandemic.
  • Close collaboration between the NIP, immunization partners (WHO, UNICEF), and guidance from NIAC were critical for successful ORI implementation.
  • The findings underscore the importance of robust surveillance and adaptive strategies in controlling infectious disease outbreaks in complex public health environments.